Effects of Gallic Acid on Antioxidant Defense System and Nrf2 Signaling in Mice with Benzene-Induced Toxicity: In Vivo, In Vitro, and Computational Study

This study demonstrates that gallic acid mitigates benzene-induced oxidative stress and hematological toxicity in mice by restoring antioxidant defenses and potentially activating the Nrf2 signaling pathway through direct binding to the Keap1 Kelch domain.

The Gist

The Big Picture: A Rusty Car and a Magic Polish

Imagine your body is a brand-new, shiny car. Benzene (a chemical found in gasoline, paints, and industrial fumes) is like a toxic, corrosive rain that falls on this car. When the rain hits, it causes rust (oxidative stress) to form rapidly. This rust eats away at the paint, weakens the metal, and eventually stops the engine from running. In humans, this "rust" damages our blood cells, heart, liver, and bones, leading to serious health issues like anemia or leukemia.

The car has its own built-in mechanics (antioxidant enzymes like SOD, CAT, and GPx) that try to scrub off the rust. But when the benzene rain is too heavy, these mechanics get overwhelmed and stop working.

Gallic Acid is the hero of this story. It's a natural compound found in berries, tea, and grapes. The researchers wanted to see if Gallic Acid could act as a "super-polish" to stop the rust and help the car's mechanics get back to work.

---

The Experiment: The Six Groups of Mice

The scientists used 36 mice to test this theory. They divided them into six groups, like different teams in a race:

1. The Healthy Team (Group A): Got water and oil. No rust, no problems.
2. The Rusty Team (Group B): Got the toxic benzene rain but no help. (This group got very sick).
3. The Standard Fix Team (Group C): Got the benzene rain plus Ascorbic Acid (Vitamin C), which is the "gold standard" for fighting rust.
4. The Gallic Acid Teams (Groups D, E, F): Got the benzene rain plus three different doses of Gallic Acid (low, medium, and high).

They ran this experiment for two weeks and then checked the mice's blood and organs.

---

What Happened? (The Results)

1. The Blood Count (Hematology)

• The Problem: The "Rusty Team" (Group B) had very low numbers of red and white blood cells. Their blood was thin and weak, like a car with no oil.
• The Fix: The mice treated with Gallic Acid (especially the medium and high doses) bounced back! Their blood cell counts returned to normal levels, looking just as healthy as the "Standard Fix Team" (Vitamin C).
• Analogy: It's like the Gallic Acid told the bone marrow, "Stop making rusty parts, start making shiny new ones!"

2. The Internal Cleanup Crew (Antioxidant Enzymes)

• The Problem: In the sick mice, the internal mechanics (enzymes) were exhausted and broken. They couldn't scrub the rust off.
• The Fix: Gallic Acid didn't just clean the rust; it recharged the batteries of the mechanics. The enzymes started working at full speed again, effectively scrubbing away the damage.
• Analogy: Imagine the mechanics were tired and sleeping. Gallic Acid woke them up, gave them coffee, and handed them better tools.

3. The Damage Report (Oxidative Stress Markers)

• The Problem: The sick mice had high levels of "rust indicators" (MDA, NO, PCO) and very low levels of "rust fighters" (GSH).
• The Fix: Gallic Acid wiped out the rust indicators and boosted the rust fighters. The internal environment of the organs (heart, liver, kidneys) became clean and safe again.

---

The Secret Weapon: How Does Gallic Acid Work? (The Molecular Docking)

This is the coolest part of the study. The scientists didn't just guess how Gallic Acid worked; they used a computer to simulate it.

The Villain: Keap1
Think of Keap1 as a strict security guard standing at the gate of a factory. His job is to catch Nrf2 (the factory manager who orders the production of cleaning supplies) and throw him in the trash (degradation) before he can do his job.

The Hero's Move
Normally, when the factory is under attack (oxidative stress), the security guard (Keap1) gets distracted or changed, allowing the manager (Nrf2) to escape and start the cleanup.

The computer simulation showed that Gallic Acid is like a clever spy. It sneaks into the security guard's pocket (the Kelch domain) and sticks there.

• The Analogy: Gallic Acid acts like a piece of gum stuck to the security guard's shoe. The guard is so busy trying to get the gum off that he can't catch the manager (Nrf2).
• The Result: The manager (Nrf2) escapes, runs to the control room (the nucleus), and shouts, "Everyone, start making cleaning supplies!" This turns on the body's natural defense system.

The computer showed that Gallic Acid stuck to the guard very tightly (strong binding), almost as well as some powerful synthetic drugs, proving it has the potential to be a very effective protector.

---

The Conclusion

In simple terms:
Exposure to benzene is like pouring acid on your body. This study proves that Gallic Acid (found in everyday foods like tea and berries) is a powerful shield. It doesn't just clean up the mess; it wakes up your body's own defense team and tricks the "bad guys" into letting them work.

The Takeaway:
If you are exposed to harsh chemicals or pollution, eating foods rich in Gallic Acid might help your body fight back. It's nature's way of giving your internal mechanics a second wind.

Note: While this study was done on mice, it provides strong evidence that this natural compound is worth investigating further for human health.

Technical Summary

1. Problem Statement

Benzene is a potent environmental and occupational toxicant known to cause myelotoxicity, hematopoietic failure, and leukemia. Its primary mechanism of toxicity involves the metabolism of benzene into reactive intermediates (e.g., benzene oxide, phenol, hydroquinone) that generate excessive Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS). This leads to:

• Oxidative Stress: Depletion of endogenous antioxidants (GSH) and inactivation of antioxidant enzymes (SOD, CAT, GPx, GST).
• Biomolecular Damage: Lipid peroxidation (elevated MDA), protein oxidation (elevated PCO), and nitrosative stress (elevated NO).
• Hematological Toxicity: Suppression of bone marrow function, resulting in anemia, leukopenia, and thrombocytopenia.
• Molecular Mechanism: Oxidative stress disrupts the Keap1-Nrf2 signaling pathway. Under normal conditions, Keap1 targets Nrf2 for degradation. While oxidative stress usually modifies Keap1 to release Nrf2, the study investigates whether specific phytochemicals can actively modulate this interaction to enhance cellular resilience.

Despite the known antioxidant properties of Gallic Acid (GA), there is a lack of integrative evidence linking its in vivo protective effects against benzene toxicity with specific molecular mechanisms involving the Keap1-Nrf2 axis and computational validation.

2. Methodology

The study employed a tripartite approach combining in vivo animal models, in vitro biochemical assays, and in silico computational modeling.

A. Experimental Design (In Vivo)

• Subjects: 36 Swiss male mice randomized into 6 groups ($n=6$).
• Induction: Benzene toxicity was induced via oral administration of 150 mg/kg body weight (diluted in sesame oil) for 14 days.
• Treatment Groups:
  • Group A: Normal control (distilled water + sesame oil).
  • Group B: Negative control (Benzene only).
  • Group C: Reference (Benzene + Ascorbic Acid 50 mg/kg).
  • Groups D, E, F: Benzene + Gallic Acid at 25, 50, and 100 mg/kg, respectively.
• Sample Collection: After 14 days, blood was collected for hematological analysis. Tissues (erythrocytes, heart, liver, kidney, femur, spleen) were harvested for biochemical analysis.

B. Biochemical Assays (In Vitro)

• Hematology: Automated analysis of WBC, RBC, HGB, HCT, PLT, LYM, MCV, MCH, and MCHC.
• Antioxidant Enzymes: Activity levels of Superoxide Dismutase (SOD), Catalase (CAT), Glutathione Peroxidase (GPx), and Glutathione S-transferase (GST).
• Oxidative Stress Biomarkers:
  • Lipid Peroxidation: Malondialdehyde (MDA) via TBA assay.
  • Protein Oxidation: Protein Carbonyls (PCO) via DNPH assay.
  • Nitrosative Stress: Nitric Oxide (NO) via Griess reaction.
  • Non-enzymatic Antioxidants: Reduced Glutathione (GSH) and Total Protein Concentration (PC).

C. Computational Study (In Silico)

• Target: Human Keap1 Kelch domain (PDB ID: 4L7B).
• Ligands: Gallic Acid, Ascorbic Acid, and four known cysteine-independent Keap1 inhibitors (PDB IDs: 1VV, 1VW, 1VX, 2FS) as controls.
• Docking: Performed using PyRx (AutoDock Vina) to assess binding affinity ($\Delta G$) and interactions within the Kelch domain binding pocket.
• ADMET: Drug-likeness and toxicity profiles were screened using DataWarrior.

D. Statistical Analysis
Data were analyzed using One-way ANOVA followed by Tukey's post-hoc test ($P < 0.05$).

3. Key Contributions

1. Integrated Validation: This study bridges the gap between computational predictions and biological reality by validating the theoretical binding of Gallic Acid to Keap1 with actual in vivo restoration of antioxidant defenses.
2. Multi-Tissue Analysis: Unlike many studies focusing solely on the liver or bone marrow, this research assessed the protective effects of Gallic Acid across a broad spectrum of tissues (heart, kidney, spleen, femur, erythrocytes, and liver).
3. Mechanistic Insight: It provides evidence suggesting that Gallic Acid acts not merely as a free radical scavenger but potentially as a direct modulator of the Keap1-Nrf2 interaction, stabilizing Nrf2 to upregulate endogenous antioxidant gene expression.

4. Key Results

Hematological Parameters

• Benzene Toxicity: Group B showed significant reductions ($P < 0.05$) in WBC, RBC, HGB, HCT, PLT, and LYM compared to controls.
• Gallic Acid Effect: Treatment with Gallic Acid (especially at 50 and 100 mg/kg) significantly reversed these deficits, restoring parameters to levels comparable to the Ascorbic Acid reference group and the normal control.

Antioxidant Enzymes and Biomarkers

• Enzyme Activity: Benzene exposure significantly suppressed SOD, CAT, GPx, and GST activities. Gallic Acid treatment restored these activities in a dose-dependent manner, with 50 and 100 mg/kg doses showing efficacy similar to Ascorbic Acid.
• Oxidative Markers:
  • Reductions: Gallic Acid significantly lowered elevated levels of MDA, PCO, and NO.
  • Restorations: It significantly increased depleted levels of GSH and total protein concentration.
  • Consistency: These improvements were observed consistently across all tested tissues (erythrocytes, heart, liver, kidney, femur, spleen).

Molecular Docking

• Binding Affinity: Gallic Acid exhibited a binding energy of -6.8 kcal/mol with the Keap1 Kelch domain, forming 18 interactions with residues including ALA366, GLY367, VAL465, and VAL512.
• Comparison: While Gallic Acid had a slightly lower binding affinity than the high-molecular-weight control inhibitors (e.g., 1VV at -10.7 kcal/mol), it demonstrated stronger binding and more interactions than Ascorbic Acid (-6.2 kcal/mol).
• Mechanism: The docking results suggest Gallic Acid binds effectively to the Kelch domain, potentially disrupting the Keap1-Nrf2 complex and preventing Nrf2 degradation.

5. Significance and Conclusion

The study concludes that Gallic Acid is a potent protective agent against benzene-induced toxicity. Its efficacy is twofold:

1. Direct Scavenging: It directly neutralizes ROS/RNS and replenishes GSH.
2. Signaling Modulation: Computational data supports the hypothesis that Gallic Acid interacts with the Keap1 Kelch domain, likely preventing the ubiquitination and degradation of Nrf2. This leads to the nuclear translocation of Nrf2 and the subsequent upregulation of antioxidant defense genes.

Clinical/Research Implications:

• Gallic Acid shows promise as a therapeutic or prophylactic agent for individuals exposed to benzene (e.g., industrial workers).
• The study validates the use of phytochemicals as Nrf2 activators, offering a strategy to enhance cellular resilience against oxidative stress beyond simple antioxidant supplementation.
• Future research should focus on isolating the specific cysteine residues or structural motifs involved in this interaction to optimize Gallic Acid derivatives for clinical use.